United States - English - NLM (National Library of Medicine)

purevive health sciences - camphor   2.8% w/v, menthol   8.8% w/v, methyl salicylate 28% w/v - external analgesic, relives minor aches and pains temporarily relieves: - arthritis pain - sore muscles - backaches stop use and ask a physician if - symptoms persist for more than 7 days - symptoms clear up and occur again within a few days - condition worsens

United States - English - NLM (National Library of Medicine)

purevive health sciences - causticurn 30c chamomille (chamomilla) 30c leopard's bane (arnica) 30c marsh tea (ledurn palustre) 30c mountain laurel (kalmia latifolia) 30c three-leaved ivy (rhus toxicodendron) 30c white bryony (bryonia alba) 30c yellow snow rose (rhododendron chrysanthum) 30c bitter sweet (dulcamara) 6c - temporarily relieves minor arthritis pain and inflammation temporarily relieves: - minor arthritis pain - inflammation stop use and ask a doctor if - you have frequent diarrhea. - symptoms persist for more than 7 days adults and children 14 years and older - take one capsule twice per day at mealtimes. children under 14 years - do not use.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 1000 mg - injection, emulsion - excipient ingredients: egg lecithin; soya oil; sodium oleate; water for injections; sodium hydroxide; glycerol - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 500 mg - injection, emulsion - excipient ingredients: soya oil; water for injections; egg lecithin; sodium oleate; glycerol; sodium hydroxide - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 200 mg - injection, emulsion - excipient ingredients: sodium oleate; egg lecithin; glycerol; water for injections; soya oil; sodium hydroxide - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 1000 mg - injection, emulsion - excipient ingredients: water for injections; glycerol; soya oil; medium chain triglycerides; sodium oleate; egg lecithin; sodium hydroxide - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 500 mg - injection, emulsion - excipient ingredients: glycerol; soya oil; sodium hydroxide; medium chain triglycerides; water for injections; egg lecithin; sodium oleate - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 200 mg - injection, emulsion - excipient ingredients: medium chain triglycerides; sodium oleate; glycerol; sodium hydroxide; water for injections; egg lecithin; soya oil - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

claris lifesciences australia pty ltd - propofol -

Australia - English - Department of Health (Therapeutic Goods Administration)

claris lifesciences australia pty ltd - propofol -